Amanda Feilding interviewed for Channel 4 Drugs:Live

05/03/2015

in Beckley in the Media

Amanda Feilding, Director of the Beckley Foundation, talks to Alan Hayling of Renegade Pictures for Channel 4’s Drugs Live: “Cannabis is an amazing medicine, that is what millions of people around the world are saying. And they’re going to the extent of breaking the law in order to take cannabis because it is medicating their problems better than what they can get legally through the doctor, at the chemist shop”.

Channel 4′s Drugs Live aired on Tuesday 3rd March 2015: Cannabis will reveal the results of a six-month trial exploring the neural underpinnings of the subjective effects experienced by users under the influence of two different varieties of cannabis: high-strength THC cannabis (‘skunk’), and balanced cannabis, which contains both THC and CBD. This research represents a breakthrough in the science of cannabinoids and confirms the importance of CBD’s therapeutic value.

The placebo-controlled, double-blind trial was carried out at UCL under the leadership of Professor Val Curran, partly in collaboration with Amanda Feilding and the Beckley Foundation. The trial consists of separate modules comparing the effects of ‘skunk’ and ‘balanced’ cannabis (vs. placebo) on brain connectivity, well-being, cognition and memory. The trial was co-funded by Channel 4, the Beckley Foundation and DrugScience.

[youtube Eo5D1b-UEy8#action=share]

 

 

Leave a Comment